HORMONAL BIOMARKERS AND MOLECULAR SUBGROUPS IN EC 155 6 Mortality Recurrence 44 (14.4) 9 (22.5) 51 (54.3) 16 (43.2) 73 (27.8) Mortality 50 (16.4) 9 (22.5) 48 (51.1) 15 (40.5) 94 (35.7) EC-related mortality 30 (9.8) 6 (15.0) 42 (44.7) 13 (35.1) 61 (23.2) Data is presented as No. (%), median (IQR) Abbreviations: NGS, Next-Generation Sequencing; EEC, endometrioid endometrial cancer; NEEC, non-endometrioid endometrial cancer; ER, estrogen receptor; PR, progesterone receptor; POLEmut, polymerase epsilon mutant; MMRd, mismatch repair deficient; p53, protein 53; NSMP, No specific molecular profile; MI, myometrial invasion; LVSI, lymphovascular space invasion; N0, negative lymph nodes, N1, positive lymph nodes; Nx, no information about the lymph nodes; FIGO, Federation International of Gynecology and Obstetrics; EBRT, external beam radition therapy; VBT, vaginal brachytherapy; EC, endometrial cancer; smMIP, single-molecule Molecular Inversion Probes; NGS, next-generation sequenting. Table S1. Continued
RkJQdWJsaXNoZXIy MTk4NDMw